BenevolentAI raises $115 million

London-based BenevolentAI, an AI company with pharmaceutical discovery and clinical development capabilities, has raised $115 million at a pre-money valuation of $2 billion, in one of the largest funding rounds in the AI pharmaceutical sector.

The majority of investors are from the United States.  The balance of raised funds came from existing investors, including Woodford Investment Management, said the company in a statement. Credit Suisse acted as the placement agent for the company. Additional details of the financing was not disclosed.

BenevolentAI has raised more than $200 million in funding since its inception in 2013. The company was founded by Ken Mulvany.

Read a blog post by Mr. Mulvany on the funding here.

[Image courtesy: BenevolentAI]

Just in

ArmorCode raises $40M

Palo Alto, Calif.-based ArmorCode, a company specializing in Application Security Posture Management (ASPM) and Risk-Based Vulnerability Management (RBVM), has raised a $40 million Series B funding round.

IBM unveils Heron processor and Quantum System Two

IBM unveiled the Quantum Heron processor at the company's annual Quantum Summit in New York on Monday, along with Quantum System Two, a modular quantum computer featuring three IBM Heron processors. 

Microsoft joins OpenAI’s board with Sam Altman officially back as CEO — The Verge

Sam Altman is officially OpenAI’s CEO again, writes Alex Heath. 

AWS, Salesforce expand strategic partnership

Amazon Web Services (AWS) and Salesforce announced an expansion of their global strategic partnership, deepening product integrations across data and artificial intelligence (AI), and for the first time offering select Salesforce products on the AWS Marketplace.